ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 267713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 267713; 2) Community: the network communities that were significantly associated with the response to NSC 267713; 3) Molecule: the relationships between components within communities and NSC 267713; 4) MDR: the compounds that were significantly associated with the NSC 267713.

NSC Compound Enrichment Correlation
NSC 407806 .delta.20:22-3,14,21-Trihydroxynorcholenic acid lactone 0.00094423800811012 0.88349785
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.000944238008110127 0.28408518
NSC 602130 13-Desoxyphomenone 0.00103112124545269 0.39610403
NSC 123111 Mitomycin derivative T 53 0.00115116014164088 0.20958681
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.00115116014164088 0.77490514
NSC 727719 (-)-Leucascandrolide A 0.00115116014164088 0.41746231
NSC 759857 Clofarabine (USAN) 0.00116011782209854 0.23339563
NSC 763241 Null 0.00116011782209854 0.11914335
NSC 212446 Null 0.00163653239752571 0.24609036
NSC 698394 Piperidine, 1,1'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1Z,3E)- 0.00163653239752573 0.3679194
Total:49  Current:2    [First] [Prev] [Next] [Last]